Upload

Loading icon Loading...

This video is unavailable.

Dr. Pasi Janne on a new lung cancer study at ASCO 2012 | Dana-Farber Cancer Institute

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like Dana-Farber Cancer Institute's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike Dana-Farber Cancer Institute's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add Dana-Farber Cancer Institute's video to your playlist.

Published on May 31, 2012

Pasi Janne, MD, PhD, Dana-Farber Cancer Institute, talks about a new study being presented at ASCO 2012 involving a clinical trial that shows the success of targeted therapies in one of the most common forms of lung cancers. The results could mean a treatment or place to start for treatment concerning this type of lung cancer.

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
to add this to Watch Later

Add to